Fidji Simo, former OpenAI executive and cofounder of biomedical startup ChronicleBio, said in an X post on Monday that she believes AI can eventually cure all diseases, but smarter models alone won't …
Fidji Simo, former CEO of Instacart and former top executive at OpenAI, has launched ChronicleBio, a startup using AI to analyze blood and segment patients with Postural Orthostatic Tachycardia Syndro…
Barnes & Noble CEO James Daunt has revived the bookstore chain by abandoning the centralized 'pay-for-display' model and empowering local stores to choose their own inventory, leading to plans to open…
ChronicleBio co-founder Fidji Simo said on August 3rd that AI's potential to cure complex chronic conditions depends on collecting deep biological data from patients over time, a resource the company …
Former OpenAI executive Fidji Simo, who left her role as CEO of AGI Deployment in July 2026 to focus on her chronic illness POTS, has launched ChronicleBio, a startup that has raised $15 million and c…
OpenAI's applications chief Fidji Simo is stepping down from her full-time role to a part-time advisory position due to a chronic neurological condition called POTS, raising concerns about leadership …